Sentinel Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-824,201
Closed -$14.1M 9
2017
Q3
$14.1M Sell
824,201
-36,900
-4% -$620K 0.34% 135
2017
Q2
$14M Buy
861,101
+69,700
+9% +$1.1M 0.34% 128
2017
Q1
$13.7M Buy
791,401
+88,219
+13% +$1.48M 0.32% 98
2016
Q4
$11.9M Sell
703,182
-291,434
-29% -$4.86M 0.3% 110
2016
Q3
$17.4M Buy
994,616
+29,000
+3% +$470K 0.42% 87
2016
Q2
$13.9M Buy
965,616
+88,616
+10% +$1.11M 0.33% 108
2016
Q1
$10.8M Buy
877,000
+53,000
+6% +$586K 0.24% 134
2015
Q4
$10M Buy
824,000
+145,900
+22% +$1.8M 0.25% 127
2015
Q3
$8.94M Buy
678,100
+160,600
+31% +$2.42M 0.23% 144
2015
Q2
$8.49M Hold
517,500
0.19% 160
2015
Q1
$9.21M Buy
517,500
+116,400
+29% +$2.16M 0.2% 155
2014
Q4
$7.63M Buy
401,100
+28,762
+8% +$487K 0.16% 159
2014
Q3
$5.11M Buy
+372,338
New +$5.31M 0.11% 188

Other funds holding ANGO

Sentinel Asset Management's ANGO Position: Q4 2017 in Review

Sentinel Asset Management sold out of AngioDynamics (ANGO) in Q4 2017, closing a stake of 824,201 shares — an estimated $14.1M sold.

Sentinel Asset Management first reported a position in ANGO in Q3 2014 and held it in 13 quarters. The position peaked at $17.4M in Q3 2016. 169 funds tracked by Wall St. Rank hold ANGO as of Q4 2017.

  • Sentinel Asset Management reported no remaining AngioDynamics position as of Q4 2017 after selling out during the quarter.
  • Sentinel Asset Management sold 824,201 AngioDynamics shares in Q4 2017, an estimated $14.1M.
  • Sentinel Asset Management first reported a position in AngioDynamics in Q3 2014 and held it in 13 quarters.
  • Sentinel Asset Management's AngioDynamics position peaked at $17.4M in Q3 2016.
  • 169 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2017.

Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.